Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2463-2475
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2463
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2463
Figure 2 Expression levels of serum biomarkers.
A: Serum GP73 expression levels in the alpha-fetoprotein (AFP)-positive hepatocellular carcinoma (HCC) and AFP-negative HCC groups and healthy subjects; B: Log-transformed des-γ-carboxyprothrombin expression levels; C: Log-transformed CK8-M65 expression levels; D: Log-transformed CK8-M30 expression levels (red represents the AFP-positive HCC group, green represents the AFP-negative HCC group, and blue represents the healthy group). HCC: Hepatocellular carcinoma.
- Citation: He L, Zhang C, Liu LL, Huang LP, Lu WJ, Zhang YY, Zou DY, Wang YF, Zhang Q, Yang XL. Development of a diagnostic nomogram for alpha-fetoprotein-negative hepatocellular carcinoma based on serological biomarkers. World J Gastrointest Oncol 2024; 16(6): 2463-2475
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2463.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2463